Medpace Holdings (MEDP) Current Deferred Revenue (2015 - 2026)

Medpace Holdings (MEDP) has reported Current Deferred Revenue for 12 consecutive years, with $904.7 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Current Deferred Revenue rose 11.86% year-over-year to $904.7 million; the trailing twelve-month figure through Jun 2026 stood at $904.7 million (up 11.86% YoY), and the FY2025 full-year result was $854.4 million, up 20.24% from the prior year.
• Current Deferred Revenue climbed to $904.7 million in Q2 2026 per MEDP's latest filing, from $856.3 million in the prior quarter.
• Across five years, Current Deferred Revenue topped out at $904.7 million in Q2 2026 and bottomed at $367.2 million in Q1 2022.
• Historically, Current Deferred Revenue has averaged $627.7 million across 5 years, with a median of $627.6 million in 2024.
• The sharpest annual moves came in 2022 and 2026: Current Deferred Revenue jumped 42.22% in 2022, then rose 11.86% in 2026.
• Over 5 years, Current Deferred Revenue stood at $462.7 million in 2022, then advanced by 20.99% to $559.9 million in 2023, then advanced by 26.92% to $710.6 million in 2024, then climbed by 20.24% to $854.4 million in 2025, then increased by 5.89% to $904.7 million in 2026.
• According to Business Quant data, Current Deferred Revenue over the past three periods registered $904.7 million, $856.3 million, and $854.4 million for Q2 2026, Q1 2026, and Q4 2025 respectively.